These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 879729)

  • 1. [Experimental study of the mutagenic activity of gentamicin sulfate in relation to the causative agent of plague].
    Kondrat'eva OV; Stepanov VM
    Antibiotiki; 1977 May; 22(5):447-9. PubMed ID: 879729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of penicillin and streptomycin for the selection of auxothrophic mutants of plague microbes].
    Suchkov IuG
    Antibiotiki; 1969 Nov; 14(11):1002-6. PubMed ID: 5378162
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
    Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of subinhibitory concentrations of antibiotics on catalase activity of plague microbes].
    Ryzhkova VV; Blagorodova NS; Mikhalevich RV; Pavlovich NV
    Antibiot Khimioter; 1992 Nov; 37(11):21-3. PubMed ID: 1300927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic sensitivity of plague microbe strains from foreign countries].
    Galenko GN; Akiev AK; Tarasova VE
    Antibiot Khimioter; 1992 Nov; 37(11):23-4. PubMed ID: 1300928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Gentamicin Concentration and Exposure Time on Intracellular
    VanCleave TT; Pulsifer AR; Connor MG; Warawa JM; Lawrenz MB
    Front Cell Infect Microbiol; 2017; 7():505. PubMed ID: 29312891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity to antibiotics of different representatives of family Yersinia].
    Martinevskiĭ IL; Stogova AG
    Antibiotiki; 1969 Jan; 14(1):61-7. PubMed ID: 4181311
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexpected results from the application of signature-tagged mutagenesis to identify Yersinia pestis genes required for adherence and invasion.
    Leigh SA; Forman S; Perry RD; Straley SC
    Microb Pathog; 2005; 38(5-6):259-66. PubMed ID: 15925275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].
    Smorodinova IuV; Shcherbaniuk AI; Ryzhko IV; Moldavan IA
    Antibiot Khimioter; 2005; 50(8-9):23-6. PubMed ID: 17016907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antistaphylococcal activity of gentamicin].
    Rosaschino F
    Minerva Med; 1975 Dec; 66(84):4505-26. PubMed ID: 1105242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic sensitivity of strains of the plague microbe isolated from foci in the Caucasus and Transcaucasia].
    Tarasova VE; Eremitskaia GN; Proskurina VA
    Antibiotiki; 1981 May; 26(5):365-7. PubMed ID: 7259143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of some aminoglycosides upon a drug dependent Escherichia coli strain.
    Gadó I; Dumbovich I
    Acta Microbiol Acad Sci Hung; 1975; 22(2):95-104. PubMed ID: 1092134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbenicillin and gentamycin. In vitro investigations of 2 broad-spectrum antibiotics active against Pseudomonas aeruginosa].
    Rosdahl N; Thomsen VF
    Ugeskr Laeger; 1971 Sep; 133(37):1817-22. PubMed ID: 5001170
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of trimethoprim sensitivity in strains of Yersinia pestis isolated from various natural foci of plague].
    Kravchenko AN; Mishan'kin BN
    Antibiot Khimioter; 1989 Jan; 34(1):42-6. PubMed ID: 2730213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999.
    Boulanger LL; Ettestad P; Fogarty JD; Dennis DT; Romig D; Mertz G
    Clin Infect Dis; 2004 Mar; 38(5):663-9. PubMed ID: 14986250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Streptomycin-resistant and streptomycin-dependent variants of the causative organism of pest].
    RUBINSHTEIN PL
    Antibiotiki (Mosc); 1956; 1(2):50-3. PubMed ID: 24544058
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chromosomal resistance of plague agent to quinolones].
    Kasatkina IV; Shcherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1991 Aug; 36(8):35-7. PubMed ID: 1661573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of effectivity of bacteriological examination and antibody neutralization reaction during the action of streptomycin on the plague microbe.
    Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):257-62. PubMed ID: 5529576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.